Advertisement

Evaluating Antigen-Specific IgE Using the Rat Basophil Leukemia Cell (RBL) Assay

  • Marsha D. W. Ward
  • Lisa B. Copeland
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1803)

Abstract

Allergic diseases (atopy) include asthma, allergic rhinitis, conjunctivitis, and allergic sinusitis. It is estimated that up to 90% of asthmatics are atopic and have an allergy trigger for asthmatic episodes. In order to assess the risk of allergy induction associated with inhalation exposure, animal models of protein allergy have been developed. These models have been used both to identify proteins as allergens and to assess their relative potency. Often these research situations include allergens that are not well characterized or are unknown. In these situations, specific allergens are not available to be evaluated by more well-known assays (such as ELISAs), and developing a specific assay to evaluate an extract or mixture for an unknown or potential allergen is very time consuming and generally requires purified antigen/allergen. Additionally, when the comparison of the relative potency of multiple extracts is of interest, a common/generic platform is necessary. A more generic method, the rat basophil leukemia cell assay (RBL assay), has been developed which provides insight into the allergenicity of extracts and mixtures as well as providing a common platform for relative potency comparison between/among these complex allergen sources.

Key words

RBL assay Relative allergenicity Cross-reactivity Allergic asthma Mouse model 

References

  1. 1.
    Viana ME, Coates NH, Gavett SH, Selgrade MJK, Vesper SJ, Ward MD (2002) An extract of Stachybotrys chartarum causes allergic asthma-like responses in a BALB/c mouse model. Toxicol Sci 70:98–109CrossRefGoogle Scholar
  2. 2.
    Ward MDW, Copeland LB, Lehmann J, Doerfler DL, Vesper SJ (2014) Assessing the allergenic potential of Molds found in water-damaged homes in a mouse model. Inhal Toxicol 26(8):474–484CrossRefGoogle Scholar
  3. 3.
    Pearce N, Pekkanen J, Beasley R (1999) How much asthma is really attributable to atopy? Thorax 54(3):268–272CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Holt PG, Macaubas C, Stumbles PA, Sly PD (1999) The role of allergy in the development of asthma. Nature 402:E12–E17CrossRefGoogle Scholar
  5. 5.
    Zhu W, Gilmour MI (2009) Comparison of allergic lung disease in three mouse strains after systemic or mucosal sensitization with ovalbumin antigen. Immunogenetics 61:199–207CrossRefPubMedGoogle Scholar
  6. 6.
    Rosenblum-Lichtenstein JH, Molina RM, Donaghey TC, Drain JD (2006) Strain differences influence murine pulmonary reposes to Stachybotrys chartarum. Am J Respir Cell Mol Biol 35:415–423CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Hoffmann A, Vieths S, Haustein D (1997) Biologic allergen assay for in vivo test allergens with an in vitro model of the murine type I reaction. J Allergy Clin Immunol 99(2):227–232CrossRefPubMedGoogle Scholar
  8. 8.
    Leadbeater D, Zhang JG, Crevel RW, Blaikie L, Basketter DA (2001) Experience with a rat basophilic leukemia cell line assay for measurement of rat or mouse specific IgE as an alternative to passive cutaneous anaphylaxis. Tox Sci Suppl 60(1):174Google Scholar
  9. 9.
    Ward MDW, Chung YJ, Copeland LB, Doerfler DL (2010) A comparison of the allergic responses induced by Penicillium chrysogenum and house dust mite extracts in a mouse model. Indoor Air 20:380–391CrossRefPubMedGoogle Scholar
  10. 10.
    Chung YJ, Copeland LB, Doerfler DL, Ward MDW (2010) The relative Allergenicity of Stachybotrys chartarum compared to house dust mite extracts in a mouse model. Inhal Toxicol 22(6):460–468CrossRefPubMedGoogle Scholar
  11. 11.
    Chung YJ, Haykal-Coates N, Viana ME, Copeland LB, Vesper SJ, Selgrade MJK, Ward MDW (2005) Dose-dependent allergic responses to an extract of Penicillium chrysogenum in BALB/c mice. Toxicology 209(1):77–89CrossRefPubMedGoogle Scholar
  12. 12.
    Ward MDW, Madison SL, Andrews DL, Sailstad DM, Gavett SH, Selgrade MJK (2000) Comparison of respiratory responses to Metarhizium anisopliae extract using two different sensitization protocols. Toxicology 147:133–145CrossRefPubMedGoogle Scholar
  13. 13.
    Giudice ED, Rinaldi L, Passarotto M, Facchinetti F, D’Arrigo A, Guiotto A, Carbonare MD, Battistin L, Leon A (2007) Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells. J Leuk Biol 81:1512–1522CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Marsha D. W. Ward
    • 1
  • Lisa B. Copeland
    • 1
  1. 1.Cardiopulmonary-Immunotoxicology Branch, National Health and Environmental Effects Laboratory, Office of Research and DevelopmentUnited States Environmental Protection AgencyResearch Triangle ParkUSA

Personalised recommendations